Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Vancomycin-resistant enterococcal urinary tract infections.

Heintz BH, Halilovic J, Christensen CL.

Pharmacotherapy. 2010 Nov;30(11):1136-49. doi: 10.1592/phco.30.11.1136. Review.

PMID:
20973687
2.

Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.

PMID:
11827558
3.

Optimizing therapy for vancomycin-resistant enterococci (VRE).

Linden PK.

Semin Respir Crit Care Med. 2007 Dec;28(6):632-45. Review.

PMID:
18095227
4.

Evaluation of the treatment of vancomycin-resistant enterococcal urinary tract infections in a large academic medical center.

Heintz BH, Cho S, Fujioka A, Li J, Halilovic J.

Ann Pharmacother. 2013 Feb;47(2):159-69. doi: 10.1345/aph.1R419.

PMID:
23341161
5.

Treatment of vancomycin-resistant Enterococcus faecium infections.

Lai KK.

Arch Intern Med. 1996 Dec 9-23;156(22):2579-84.

PMID:
8951301
6.

Therapeutic options for infections due to vancomycin-resistant enterococci.

Wang JL, Hsueh PR.

Expert Opin Pharmacother. 2009 Apr;10(5):785-96. doi: 10.1517/14656560902811811 . Review.

PMID:
19351228
7.

Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy.

Shea K, Hilburger E, Baroco A, Oldfield E.

Ann Pharmacother. 2008 May;42(5):722-5. doi: 10.1345/aph.1K561.

PMID:
18349306
9.

Treatment of resistant enterococcal urinary tract infections.

Swaminathan S, Alangaden GJ.

Curr Infect Dis Rep. 2010 Nov;12(6):455-64. doi: 10.1007/s11908-010-0138-8.

PMID:
21308555
10.

Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.

Descourouez JL, Jorgenson MR, Wergin JE, Rose WE.

Antimicrob Agents Chemother. 2013 Mar;57(3):1518-20. doi: 10.1128/AAC.02099-12.

12.

Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections.

Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE.

Clin Infect Dis. 2012 Apr;54 Suppl 3:S233-8. doi: 10.1093/cid/cir924.

PMID:
22431854
13.

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).

Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ; NAVRESS Group..

J Antimicrob Chemother. 2003 Sep;52(3):382-8.

PMID:
12888592
14.

Emergence and management of drug-resistant enterococcal infections.

Arias CA, Murray BE.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):637-55. doi: 10.1586/14787210.6.5.637. Review.

PMID:
18847403
15.

Epidemiology of bacteriuria caused by vancomycin-resistant enterococci--a retrospective study.

Wong AH, Wenzel RP, Edmond MB.

Am J Infect Control. 2000 Aug;28(4):277-81.

PMID:
10926703
16.

Vancomycin-resistant enterococci.

McGeer AJ, Low DE.

Semin Respir Infect. 2000 Dec;15(4):314-26. Review.

PMID:
11220414
17.
18.
19.

Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype)

Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K.

J Clin Microbiol. 1997 Dec;35(12):3166-70. Erratum in: J Clin Microbiol 1998 May;36(5):1469.

20.

Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin.

Shrestha NK, Chua JD, Tuohy MJ, Wilson DA, Procop GW, Longworth DL, Isada CM, Hall GS.

Scand J Infect Dis. 2003;35(1):12-4.

PMID:
12685877

Supplemental Content

Support Center